Characterizing immunocompetent models of PSMA plus prostate cancer to investigate [225Ac]Ac-PSMA-617 efficacy in mice

被引：0
|
作者：
Taddio, Marco [1 ]
Rodriguez, Arely Perez [2 ]
Azrour, Ines [1 ]
Richard, Mathis [1 ]
Vilangattil, Meryl [1 ]
Jeanjean, Pauline [3 ]
Besserer-Offroy, Elie [4 ]
Carlucci, Giuseppe [1 ]
Czernin, Johannes [1 ]
Mona, Christine [1 ]
机构：
[1] Univ Calif Los Angeles, Ahmanson Translat Theranost Div, Pharmacol, Los Angeles, CA USA
[2] UCLA, Ahmanson Translat Theranost Div, Pharmacol, Los Angeles, CA USA
[3] UCLA, Los Angeles, CA USA
[4] Univ Calif Los Angeles, Ahmanson Translat Theranost Div, Los Angeles, CA USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P1216
引用
收藏
页数：3
相关论文
共 50 条
  • [41] 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study
    Sathekge, Mike
    Bruchertseifer, Frank
    Knoesen, Otto
    Reyneke, Florette
    Lawal, Ismaheel
    Lengana, Thabo
    Davis, Cindy
    Mahapane, Johncy
    Corbett, Ceceila
    Vorster, Mariza
    Morgenstern, Alfred
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (01) : 129 - 138
  • [42] 225Ac-PSMA-617 Targeted Alpha Therapy in Metastatic Castration Resistant Prostate Cancer Patients
    Yadav, Madhav
    Ballal, Sanjana
    Tripathi, Madhavi
    Bal, Chandrasekhar
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62
  • [43] Reducing the Effective Specific Activity of [225Ac]-PSMA-617 to Minimize Salivary Gland and Renal Toxicity
    Esposito, T.
    Kalidindi, T.
    Payne, R.
    Faudemer, Z.
    Jones, K.
    Pillarsetty, N.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S344 - S344
  • [44] Dose-dependent relative biological effectiveness of 225Ac compared to 177Lu during [225Ac]Ac-PSMA and [177Lu]Lu-PSMA radionuclide therapy
    Rumiantcev, M.
    Li, W.
    Lindner, S.
    Liubchenko, G.
    Resch, S.
    Bartenstein, P.
    Ziegler, S.
    Boening, G.
    Delker, A.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S363 - S363
  • [45] Efficacy and safety of 225Ac-PSMA-617 targeted alpha therapy in metastatic castration-resistant Prostate Cancer patients
    Yadav, Madhav Prasad
    Ballal, Sanjana
    Sahoo, Ranjit Kumar
    Tripathi, Madhavi
    Seth, Amlesh
    Bal, Chandrasekhar
    THERANOSTICS, 2020, 10 (20): : 9364 - 9377
  • [46] Efficacy and Safety of 225Ac-PSMA-617 Targeted Alpha Therapy in Metastatic Castration-Resistant Prostate Cancer Patients
    Yadav, M.
    Ballal, S.
    Bal, C.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2020, 47 (SUPPL 1) : S420 - S420
  • [47] Correction to: 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: a pilot study
    Mike Sathekge
    Frank Bruchertseifer
    Otto Knoesen
    Florette Reyneke
    Ismaheel Lawal
    Thabo Lengana
    Cindy Davis
    Johncy Mahapane
    Ceceila Corbett
    Mariza Vorster
    Alfred Morgenstern
    European Journal of Nuclear Medicine and Molecular Imaging, 2019, 46 : 1988 - 1988
  • [48] Tandem Isotope Therapy with 225Ac-and 177Lu-PSMA-617 in a Murine Model of Prostate Cancer
    Meyer, Catherine
    Stuparu, Andreea
    Lueckerath, Katharina
    Calais, Jeremie
    Czernin, Johannes
    Slavik, Roger
    Dahlbom, Magnus
    JOURNAL OF NUCLEAR MEDICINE, 2023, 64 (11) : 1772 - 1778
  • [49] The role of 225Ac-PSMA-617 in chemotherapy-naive patients with advanced prostate cancer: Is it the new beginning
    Agrawal, Sumit
    INDIAN JOURNAL OF UROLOGY, 2020, 36 (01) : 69 - 70
  • [50] Evaluation of the tolerability and safety of [225Ac]Ac-PSMA-I&T in patients with metastatic prostate cancer: a phase I dose escalation study
    Sui wai Ling
    Astrid A. M. van der Veldt
    Mark Konijnenberg
    Marcel Segbers
    Eline Hooijman
    Frank Bruchertseifer
    Alfred Morgenstern
    Erik de Blois
    Tessa Brabander
    BMC Cancer, 24
12345